Table of Contents
Chapter 1. Global Cytogenetics Market Executive Summary
1.1. Global Cytogenetics Market Size & Forecast (2022- 2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Technique
1.3.3. By Application
1.3.4. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Cytogenetics Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Cytogenetics Market Dynamics
3.1. Market Drivers
3.1.1. Rising Incidence of Genetic Disorders and Cancer
3.1.2. Increase in Focus on Targeted Cancer Treatment
3.2. Market Challenges
3.2.1. High Cost of Cytogenetic Instruments
3.2.2. Limited Awareness in Emerging Economies
3.3. Market Opportunities
3.3.1. Transition to Array-Based Techniques
3.3.2. Growth in Personalized Medicine
Chapter 4. Global Cytogenetics Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Cytogenetics Market Size & Forecasts by Product 2022-2032
5.1. Segment Dashboard
5.2. Consumables
5.3. Instruments
5.4. Software & Services
Chapter 6. Global Cytogenetics Market Size & Forecasts by Technique 2022-2032
6.1. Segment Dashboard
6.2. Comparative Genomic Hybridization
6.3. Fluorescence in Situ Hybridization
6.4. Karyotyping
6.5. Immunohistochemistry
6.6. Others
Chapter 7. Global Cytogenetics Market Size & Forecasts by Application 2022-2032
7.1. Segment Dashboard
7.2. Genetic Disorders
7.3. Cancer
7.4. Personalized Medicine
7.5. Others
Chapter 8. Global Cytogenetics Market Size & Forecasts by End User 2022-2032
8.1. Segment Dashboard
8.2. Clinical & Research Laboratories
8.3. Pharmaceutical & Biotechnology
8.4. Academic Research Institutes
8.5. Others
Chapter 9. Global Cytogenetics Market Size & Forecasts by Region 2022-2032
9.1. North America Cytogenetics Market
9.1.1. U.S. Cytogenetics Market
9.1.1.1. By Product breakdown size & forecasts, 2022-2032
9.1.1.2. By Technique breakdown size & forecasts, 2022-2032
9.1.1.3. By Application breakdown size & forecasts, 2022-2032
9.1.1.4. By End User breakdown size & forecasts, 2022-2032
9.1.2. Canada Cytogenetics Market
9.2. Europe Cytogenetics Market
9.2.1. U.K. Cytogenetics Market
9.2.2. Germany Cytogenetics Market
9.2.3. France Cytogenetics Market
9.2.4. Italy Cytogenetics Market
9.2.5. Spain Cytogenetics Market
9.2.6. Rest of Europe Cytogenetics Market
9.3. Asia-Pacific Cytogenetics Market
9.3.1. China Cytogenetics Market
9.3.2. India Cytogenetics Market
9.3.3. Japan Cytogenetics Market
9.3.4. Australia Cytogenetics Market
9.3.5. South Korea Cytogenetics Market
9.3.6. Rest of Asia-Pacific Cytogenetics Market
9.4. Latin America Cytogenetics Market
9.4.1. Brazil Cytogenetics Market
9.4.2. Mexico Cytogenetics Market
9.4.3 Rest of Latin America Cytogenetics Market
9.5. Middle East and Africa Cytogenetics Market
9.4.2. Saudi Arabia Cytogenetics Market
9.4.3. South Africa Cytogenetics Market
9.4.4. Rest of Middle East and Africa Cytogenetics Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Company 1.
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Applied Spectral Imaging, Inc.
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. Illumina, Inc.
10.3.3. Abbott Laboratories
10.3.4. Irvine Scientific
10.3.5. OPKO Health, Inc.
10.3.6. Thermo Fisher Scientific, Inc.
10.3.7. Agilent Technologies, Inc.
10.3.8. PerkinElmer, Inc.
10.3.9. Sysmex Corporation
10.3.10. Empire Genomics, LLC
10.3.11. Bio-Rad Laboratories, Inc.
10.3.12. F. Hoffmann-La Roche Ltd.
10.3.13. MetaSystems
10.3.14. Oxford Gene Technology
10.3.15. CytoTest Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes